Vimarsana
Biggest News Aggregation in the World

Page 30 - Exchange Consideration News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exchange Consideration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exchange Consideration Today - Breaking & Trending Today

Biogen Inc.: Biogen Announces the Expiration Date Results of Its Private Exchange Offer - Vimarsana News

Biogen Inc.: Biogen Announces the Expiration Date Results of Its Private Exchange Offer

Biogen Inc.: Biogen Announces the Expiration Date Results of Its Private Exchange Offer CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. ("Biogen") (Nasdaq: BIIB) today announced the expiration date results of its previously announced private offer to exchange (the "Exchange Offer") any and all of its outstanding 5.200% Senior Notes due 2045 (the "Old Notes"), totaling $1.75 billion in aggregate principal amount, for a new series of 3.250% senior notes due 2051 to be issued by Biogen (the "New Notes") and cash on the terms and subject to conditions set forth in the Offering M...

Biogen Inc.: Biogen Announces the Pricing Terms of Its Private Exchange Offer - Vimarsana News

Biogen Inc.: Biogen Announces the Pricing Terms of Its Private Exchange Offer

Biogen Inc.: Biogen Announces the Pricing Terms of Its Private Exchange Offer CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. ("Biogen") (Nasdaq: BIIB) today announced the pricing terms of its previously announced private offer to exchange (the "Exchange Offer") any and all of its outstanding 5.200% Senior Notes due 2045 (the "Old Notes"), totaling $1.75 billion in aggregate principal amount, for a new series of 3.250% senior notes due 2051 to be issued by Biogen (the "New Notes") and cash on the terms and subject to the conditions set forth in the Offering Memorandum dated ...

Investegate |Biogen Inc. Announcements | Biogen Inc.: Biogen Announces the Pricing Terms of Its Private Exchange Offer - Vimarsana News

Investegate |Biogen Inc. Announcements | Biogen Inc.: Biogen Announces the Pricing Terms of Its Private Exchange Offer

Biogen Announces the Pricing Terms of Its Private Exchange Offer CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the pricing terms of its previously announced private offer to exchange (the “Exchange Offer”) any and all of its outstanding 5.200% Senior Notes due 2045 (the “Old Notes”), totaling $1.75 billion in aggregate principal amount, for a new series of 3.250% senior notes due 2051 to be issued by Biogen (the “New Notes”) and cash on the terms and subject to the conditions set forth in the Offering Memorandum da...

YPF Sociedad Anónima Announces Fourth Amendment to Exchange Offers and Consent Solicitation - Vimarsana News

YPF Sociedad Anónima Announces Fourth Amendment to Exchange Offers and Consent Solicitation

YPF Sociedad Anónima Announces Fourth Amendment to Exchange Offers and Consent Solicitation News provided by Share this article YPF" or the " Company") today announced its decision to amend the terms and conditions of its amended and restated Exchange Offer and Consent Solicitation Memorandum dated January 25, 2021, as amended on February 1, 2021 (the " Exchange Offer and Consent Solicitation Memorandum"). Capitalized terms used herein and not otherwise defined shall have the meaning ascribed to them in the Exchange Offer and Consent Solicitation Memorandum. YPF has continued to engage throu...

YPF Sociedad Anónima Announces Second Amendment to Exchange Offers and Consent Solicitation - Vimarsana News

YPF Sociedad Anónima Announces Second Amendment to Exchange Offers and Consent Solicitation

YPF Sociedad Anónima Announces Second Amendment to Exchange Offers and Consent Solicitation News provided by Share this article YPF" or the " Company") today announced its decision to amend the terms and conditions of its Exchange Offers and Consent Solicitation initially described in its Exchange Offer and Consent Solicitation Memorandum dated January 7, 2021, as first amended on January 14, 2021 (the " Exchange Offer and Consent Solicitation Memorandum"). Capitalized terms used herein and not otherwise defined shall have the meaning ascribed to them in the Exchange Offer and Consent Solici...